StockNews.com Begins Coverage on Vascular Biogenics (NASDAQ:VBLT)
StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a research note published on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance Shares of VBLT stock opened at $0.17 on Friday. The stock has a market cap of $11.86 million, a P/E ratio […]